SOHM Inc | Adds Life to LivesAdds life to lives

SOHM Projects 2012 to be another Record Revenue Year

posted in Press Releases article tags:

SOHM Expects revenue to more than double by end of 2012

BUENA PARK, CA–(Marketwire – February 25, 2012) – SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceuticals, and nutraceutical company that manufactures and markets generic drugs covering all major treatment categories, today announced its financial outlook for Year 2012:

Ø SOHM planned outlook for year 2012 is to generate $2,900,000 in revenue with profitability. SOHM project a continued revenue growth during 2012 as similar to previous years. SOHM projected $1,250,000 for 2011 and by-passed that projection and generated $1,349,341 in revenue in the fiscal year of 2011. Actual revenue was an increase of $567,666 that is an improvement of 72% as compared to revenue of fiscal year 2010. By end of fiscal year 2012 SOHM projects revenue growth of more than 100% as compared to 2011.

Ø During 2012 company has planned this exponential growth of over 100% in revenue expansion of its infrastructure, growth of distribution network and increase of products in generic drugs, nutraceuticals and dermatology division. The company is actively looking at several acquisitions to increase product range and revenue growth.

“All the way through 2011, we progressed to raise our revenue by attaining significant growth in our marketed products nationally as well as globally. We expect a similar type of pattern during 2012”, commented Mr. Shailesh Shah, Sohm Inc. President and CEO, “As anticipated, we are getting substantial benefits from the recent acquisition and development, buttressed our management potentialities. SOHM Outlook 2012 is to execute successful business strategies.”

About Sohm, Inc.

Sohm Inc, a growing generic pharmaceutical manufacturing and marketing company, has its global presence with a goal to gain continuous growth. The company has its presence in versatile healthcare segments such as Nutraceuticals, Dermatology and all other major therapeutic segments. Sohm is headquartered in North America along with its manufacturing units in India. Sohm’s generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia mainly. To know more about Sohm Inc., please visit

Forward-Looking Statements

This press release is containing many safe harbour statements such as “anticipating”, “approximately”, “expect”, “goal”, “unaudited”, “project”, “plan”, “will”, etc., keeping in mind the guidelines of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:

Andrew Barwicki

SOHM, Inc.